Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Jahanzeb

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|May 15, 2003
Trastuzumab-based combinations in metastatic breast cancer: how to make a choiceMohammad Jahanzeb
The Oncologist|July 14, 2026
Patient-driven second opinions in oncology: A reviewMohammad Jahanzeb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Continuing trastuzumab beyond progressionMohammad Jahanzeb
Clinical Therapeutics|October 9, 2007
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal womenMohammad Jahanzeb
Clinical Breast Cancer|September 2, 2008
Adjuvant trastuzumab therapy for HER2-positive breast cancerMohammad Jahanzeb
Clinical Lung Cancer|October 29, 2008
Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directionsJeffrey Allen, Mohammad Jahanzeb
Journal of the National Comprehensive Cancer Network : JNCCN|April 2, 2008
Neoadjuvant chemotherapy in stage III NSCLCJeffrey Allen, Mohammad Jahanzeb
Clinical Breast Cancer|October 6, 2010
Bisphosphonates as anticancer therapy for early breast cancerReshma Mahtani, Mohammad Jahanzeb
Lung Cancer Management|January 16, 2019
Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinomaSean Warsch, Mohammad Jahanzeb
Seminars in Oncology|August 5, 2010
Bisphosphonates in lung cancer: more than a palliative therapy?Mohammad Jahanzeb, Vera Hirsh
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|May 15, 2003
Trastuzumab-based combinations in metastatic breast cancer: how to make a choiceMohammad Jahanzeb
The Oncologist|July 14, 2026
Patient-driven second opinions in oncology: A reviewMohammad Jahanzeb
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Continuing trastuzumab beyond progressionMohammad Jahanzeb
Clinical Therapeutics|October 9, 2007
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal womenMohammad Jahanzeb
Clinical Breast Cancer|September 2, 2008
Adjuvant trastuzumab therapy for HER2-positive breast cancerMohammad Jahanzeb
Clinical Lung Cancer|October 29, 2008
Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directionsJeffrey Allen, Mohammad Jahanzeb
Journal of the National Comprehensive Cancer Network : JNCCN|April 2, 2008
Neoadjuvant chemotherapy in stage III NSCLCJeffrey Allen, Mohammad Jahanzeb
Clinical Breast Cancer|October 6, 2010
Bisphosphonates as anticancer therapy for early breast cancerReshma Mahtani, Mohammad Jahanzeb
Lung Cancer Management|January 16, 2019
Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinomaSean Warsch, Mohammad Jahanzeb
Seminars in Oncology|August 5, 2010
Bisphosphonates in lung cancer: more than a palliative therapy?Mohammad Jahanzeb, Vera Hirsh
Pageof 8